ARYX OTC
ARYx Therapeutics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +25.0%
5Y: -72.2%
$0.00
Last traded 2026-08-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$12M
-75.7% ▼
5Y CAGR: +7.0%
Total Liabilities
$15M
-35.4% ▼
Shareholders Equity
-$3M
-110.6% ▼
Cash & Investments
$8M
-82.6% ▼
Total Debt
$12M
-20.3% ▼
Net Debt
$4M
+120.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $12M | $19M | $55M | $36M | $7M |
| Short-Term Investments | $14M | $32M | $8M | $9M | $353K |
| Cash & ST Investments | $26M | $50M | $63M | $45M | $8M |
| Net Receivables | $0 | $45K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $150K | $0 | $150K |
| Total Current Assets | $28M | $51M | $65M | $46M | $9M |
| Property, Plant & Equip. | $4M | $4M | $4M | $3M | $2M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $1M | $1M | $1M | $2M | $1M |
| Total Non-Current Assets | $6M | $5M | $5M | $5M | $4M |
| Total Assets | $33M | $57M | $70M | $51M | $12M |
| — Liabilities — | |||||
| Accounts Payable | $656K | $691K | $1M | $2M | $685K |
| Short-Term Debt | $2M | $3M | $4M | $3M | $5M |
| Deferred Revenue | $4M | $4M | $4M | $5M | $0 |
| Other Current Liabilities | $4M | $1M | $0 | $4M | $0 |
| Total Current Liabilities | $8M | $12M | $13M | $11M | $9M |
| Long-Term Debt | $9M | $7M | $3M | $11M | $6M |
| Other Non-Current Liab. | $84M | $132M | $17M | $0 | $0 |
| Total Non-Current Liabilities | $93M | $139M | $21M | $13M | $7M |
| Total Liabilities | $100M | $150M | $34M | $24M | $15M |
| — Equity — | |||||
| Common Stock | $1K | $1K | $18K | $27K | $28K |
| Retained Earnings | -$68M | -$95M | -$123M | -$154M | -$187M |
| Accumulated OCI | -$298K | $0 | $0 | $45K | $0 |
| Total Stockholders Equity | -$67M | -$94M | $35M | $27M | -$3M |
| Total Liabilities & Equity | $33M | $57M | $70M | $51M | $12M |
| — Key Metrics — | |||||
| Total Debt | $11M | $10M | $7M | $15M | $12M |
| Net Debt | -$1M | -$9M | -$48M | -$21M | $4M |
| Total Investments | $14M | $32M | $8M | $9M | $353K |